N-Desmethylclozapine, a Major Metabolite of Clozapine, Increases Cortical Acetylcholine and Dopamine Release In Vivo Via Stimulation of M1 Muscarinic Receptors
- 18 May 2005
- journal article
- research article
- Published by Springer Science and Business Media LLC in Neuropsychopharmacology
- Vol. 30 (11), 1986-1995
- https://doi.org/10.1038/sj.npp.1300768
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Predictors of Clinical Outcome in Schizophrenic Patients Responding to ClozapineJournal of Clinical Psychopharmacology, 2003
- Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant miceNature Neuroscience, 2002
- Clozapine in Patients with Chronic Schizophrenia: Serum Level, EEG and Memory PerformancePharmacopsychiatry, 2002
- Simultaneous determination of clozapine and its N-desmethyl and N-oxide metabolites in plasma by liquid chromatography/electrospray tandem mass spectrometry and its application to plasma level monitoring in schizophrenic patients.Journal of Pharmaceutical and Biomedical Analysis, 2001
- Low Muscarinic Receptor Binding in Prefrontal Cortex From Subjects With Schizophrenia: A Study of Brodmann’s Areas 8, 9, 10, and 46 and the Effects of Neuroleptic Drug TreatmentAmerican Journal of Psychiatry, 2001
- Effects of Desmethylclozapine on Fos Protein Expression in the Forebrain: In Vivo Biological Activity of the Clozapine MetaboliteNeuropsychopharmacology, 1998
- Clozapine is a potent and selective muscarinic M4 receptor agonistEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- Clozapine and N-desmethylclozapine are potent 5-HT1C receptor antagonistsEuropean Journal of Pharmacology: Molecular Pharmacology, 1993
- THE ROLE OF THE NUCLEUS BASALIS OF MEYNERT IN DEMENTIA: REVIEW AND RECONSIDERATIONAlzheimer Disease & Associated Disorders, 1987
- Cloning, sequencing and expression of complementary DNA encoding the muscarinic acetylcholine receptorNature, 1986